BUZZ-U.S. Stocks on the Move-Cliffs Natural, Rockwell Medical, Palo Alto
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were higher on Friday after the September jobs report came in ahead of expectations, though major indexes remained on track for a second straight weekly decline. The Dow Jones industrial average was up 0.77 percent at 16,929.61 and the S&P 500 was up 0.86 percent at 1,962.86.
** ROCKWELL MEDICAL INC, $10.74, +16.99 pct
The drug developer signed a marketing agreement with a unit of Baxter International Inc, according to which Baxter will sell Rockwell's hemodialysis solutions and powders in the United States and selected overseas markets for 10 years.
Baxter will pay $20 million in cash for exclusive commercial rights and buy $15 million of company's common stock, Rockwell said.
** DURATA THERAPEUTICS INC, $13.42, +13.44 pct
The company said it received a special protocol assessment agreement from the U.S. Food and Drug Administration for its late-stage study on its pneumonia drug, Dalvance.
A special protocol assessment agreement is a declaration by the FDA that the company's trial design and endpoints are acceptable for an approval. Continued...